Turen, S. Et Al. 2004. Serum LDH level is a prognostic factor in locoregionally advanced nasopharyngeal carcinoma (NPC) patients treated with chemoradiotherapy. 3rd International Chicago Symposium on Malignancies of the Chest and Head and Neck , (Illinois, United States Of America).

Turen, S., Ozyar, E., Altundag, M., & Gullu, I., (2004). Serum LDH level is a prognostic factor in locoregionally advanced nasopharyngeal carcinoma (NPC) patients treated with chemoradiotherapy . 3rd International Chicago Symposium on Malignancies of the Chest and Head and Neck, Illinois, United States Of America

Turen, S Et Al. "Serum LDH level is a prognostic factor in locoregionally advanced nasopharyngeal carcinoma (NPC) patients treated with chemoradiotherapy," 3rd International Chicago Symposium on Malignancies of the Chest and Head and Neck, Illinois, United States Of America, 2004

Turen, S Et Al. "Serum LDH level is a prognostic factor in locoregionally advanced nasopharyngeal carcinoma (NPC) patients treated with chemoradiotherapy." 3rd International Chicago Symposium on Malignancies of the Chest and Head and Neck , Illinois, United States Of America, 2004

Turen, S. Et Al. (2004) . "Serum LDH level is a prognostic factor in locoregionally advanced nasopharyngeal carcinoma (NPC) patients treated with chemoradiotherapy." 3rd International Chicago Symposium on Malignancies of the Chest and Head and Neck , Illinois, United States Of America.

@conferencepaper{conferencepaper, author={S Turen Et Al. }, title={Serum LDH level is a prognostic factor in locoregionally advanced nasopharyngeal carcinoma (NPC) patients treated with chemoradiotherapy}, congress name={3rd International Chicago Symposium on Malignancies of the Chest and Head and Neck}, city={Illinois}, country={United States Of America}, year={2004}}